Newly approved clot-busting drug works as well as traditional drug for stroke, research shows
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
Physician's Weekly1h
Elevated Stroke Risk in Individuals With COVID 19
The following is a summary of “Association between SARS-CoV-2 and stroke: perspectives from a metaumbrella-review,” published in the March 2025 issue of BMC Neurology by Baldo de Souza et al. The ...
Medscape4h
Intra-arterial Thrombolysis Fails to Improve Stroke Outcomes
Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...
The Cardiology Advisor20h
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Infectious Disease Advisor23h
Patients With COVID-19 Have Worse Recovery Outcomes Following Ischemic Stroke
A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.